A new review of real-world data on the use of the diabetes drug semaglutide has offered some reassuring news about its impact on vision

Associate Professor Simon Skalicky has been recognised as the winner of SmartCompany’s final early-stage start-up competition for 2023, announced on 30 November.

A clinical study has demonstrated that Shamir’s new myopia control lens – Optimee – can control the progression of myopia and ensure long-term vision

Next-generation, ‘customised’ laser eye technology could deliver high-definition (HD) vision for more than seven million Australian adults living with myopia and astigmatism.1